PR Newswire
AUSTIN, Texas, April 26, 2017
AUSTIN, Texas, April 26, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its first quarter 2017 financial results on Thursday, May 11, 2017, followed by an investor conference call and webcast at 8:30 a.m. Eastern Time.
Thursday, May 11th @ 8:30am Eastern Time | |
Domestic: |
888-596-2629 |
International: |
913-312-0678 |
Conference ID: |
3158379 |
Webcast: |
|
Replays, available through May 25th: | |
Domestic: |
844-512-2921 |
International: |
412-317-6671 |
Replay PIN: |
3158379 |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
Tel 1-646-597-6983
[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vermillion-to-report-first-quarter-2017-financial-results-and-host-investor-conference-call-on-may-11-300446520.html
SOURCE Vermillion, Inc.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member